Insider Transactions in Q3 2022 at Catalent, Inc. (CTLT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2022
|
Karen Murphy Santiago VP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,421
+45.49%
|
-
|
|
Sep 15
2022
|
Karen Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
245
+1.82%
|
-
|
|
Aug 31
2022
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Open market or private sale
|
Direct |
2,216
-11.48%
|
$197,224
$89.59 P/Share
|
|
Aug 26
2022
|
Michael A. Riley Pres. Bio Product Delivery Div |
SELL
Open market or private sale
|
Direct |
2,491
-27.42%
|
$259,064
$104.07 P/Share
|
|
Aug 26
2022
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
1,639
-6.4%
|
$170,456
$104.07 P/Share
|
|
Aug 25
2022
|
Kay A Schmidt SVP, Enterprise Functions |
SELL
Open market or private sale
|
Direct |
1,321
-7.06%
|
$136,063
$103.04 P/Share
|
|
Aug 25
2022
|
Michael A. Riley Pres. Bio Product Delivery Div |
SELL
Open market or private sale
|
Direct |
1,482
-14.03%
|
$152,646
$103.04 P/Share
|
|
Aug 25
2022
|
Ricardo Pravda Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
1,747
-8.03%
|
$179,941
$103.04 P/Share
|
|
Aug 25
2022
|
Alessandro Maselli President & CEO |
SELL
Open market or private sale
|
Direct |
4,646
-10.14%
|
$478,538
$103.04 P/Share
|
|
Aug 25
2022
|
Patricia Hunt Pres. Consumer Health Div |
SELL
Open market or private sale
|
Direct |
339
-3.51%
|
$34,917
$103.04 P/Share
|
|
Aug 25
2022
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Open market or private sale
|
Direct |
1,517
-7.28%
|
$156,251
$103.04 P/Share
|
|
Aug 25
2022
|
Thomas W Hawkeswood Pres. Pharma Prod Delivery Div |
SELL
Open market or private sale
|
Direct |
671
-9.63%
|
$69,113
$103.04 P/Share
|
|
Aug 25
2022
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
1,840
-6.7%
|
$189,520
$103.04 P/Share
|
|
Aug 25
2022
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
1,670
-7.62%
|
$172,010
$103.04 P/Share
|
|
Aug 25
2022
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
SELL
Open market or private sale
|
Direct |
1,645
-1.86%
|
$169,435
$103.04 P/Share
|
|
Aug 25
2022
|
Mario Gargiulo SVP, Ops, Biologics Europe |
SELL
Open market or private sale
|
Direct |
1,586
-19.97%
|
$163,358
$103.04 P/Share
|
|
Aug 25
2022
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
4,811
-7.22%
|
$495,533
$103.04 P/Share
|
|
Aug 25
2022
|
John R Chiminski Executive Chair |
SELL
Open market or private sale
|
Direct |
38,934
-14.48%
|
$4,010,202
$103.04 P/Share
|
|
Aug 25
2022
|
Thomas P Castellano SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,414
-6.57%
|
$145,642
$103.04 P/Share
|
|
Aug 25
2022
|
Lorenzo Carletti SVP Global Ops Ph & Cons Hlth |
SELL
Open market or private sale
|
Direct |
1,033
-17.17%
|
$106,399
$103.04 P/Share
|
|
Aug 25
2022
|
Manja Boerman Pres. BioModalities Division |
SELL
Open market or private sale
|
Direct |
3,296
-16.53%
|
$339,488
$103.04 P/Share
|
|
Aug 25
2022
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
SELL
Open market or private sale
|
Direct |
384
-0.68%
|
$39,552
$103.04 P/Share
|
|
Aug 24
2022
|
Kay A Schmidt SVP, Enterprise Functions |
BUY
Grant, award, or other acquisition
|
Direct |
4,139
+18.12%
|
-
|
|
Aug 24
2022
|
Michael A. Riley Pres. Bio Product Delivery Div |
BUY
Grant, award, or other acquisition
|
Direct |
3,973
+27.33%
|
-
|
|
Aug 24
2022
|
Ricardo Pravda Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,117
+19.04%
|
-
|
|
Aug 24
2022
|
Alessandro Maselli President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,532
+18.68%
|
-
|
|
Aug 24
2022
|
Patricia Hunt Pres. Consumer Health Div |
BUY
Grant, award, or other acquisition
|
Direct |
949
+8.95%
|
-
|
|
Aug 24
2022
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
3,733
+15.2%
|
-
|
|
Aug 24
2022
|
Thomas W Hawkeswood Pres. Pharma Prod Delivery Div |
BUY
Grant, award, or other acquisition
|
Direct |
1,253
+15.25%
|
-
|
|
Aug 24
2022
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
5,117
+15.7%
|
-
|
|
Aug 24
2022
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
4,890
+18.24%
|
-
|
|
Aug 24
2022
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
6,771
+7.11%
|
-
|
|
Aug 24
2022
|
Mario Gargiulo SVP, Ops, Biologics Europe |
BUY
Grant, award, or other acquisition
|
Direct |
3,432
+30.18%
|
-
|
|
Aug 24
2022
|
Steven L Fasman EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,155
+13.22%
|
-
|
|
Aug 24
2022
|
John R Chiminski Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
99,275
+26.97%
|
-
|
|
Aug 24
2022
|
Thomas P Castellano SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,139
+16.14%
|
-
|
|
Aug 24
2022
|
Lorenzo Carletti SVP Global Ops Ph & Cons Hlth |
BUY
Grant, award, or other acquisition
|
Direct |
2,232
+27.05%
|
-
|
|
Aug 24
2022
|
Manja Boerman Pres. BioModalities Division |
BUY
Grant, award, or other acquisition
|
Direct |
6,676
+25.09%
|
-
|
|
Aug 24
2022
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
BUY
Grant, award, or other acquisition
|
Direct |
6,621
+10.52%
|
-
|
|
Jul 27
2022
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Open market or private sale
|
Direct |
591
-3.34%
|
$63,237
$107.67 P/Share
|
|
Jul 27
2022
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
394
-1.73%
|
$42,158
$107.67 P/Share
|
|
Jul 27
2022
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
388
-2.23%
|
$41,516
$107.67 P/Share
|
|
Jul 26
2022
|
Kay A Schmidt SVP, Enterprise Functions |
BUY
Grant, award, or other acquisition
|
Direct |
1,115
+7.11%
|
-
|
|
Jul 26
2022
|
Kay A Schmidt SVP, Enterprise Functions |
SELL
Open market or private sale
|
Direct |
323
-2.34%
|
$34,238
$106.9 P/Share
|
|
Jul 26
2022
|
Ricardo Pravda Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,301
+7.25%
|
-
|
|
Jul 26
2022
|
Ricardo Pravda Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
427
-2.71%
|
$45,262
$106.9 P/Share
|
|
Jul 26
2022
|
Alessandro Maselli President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+22.45%
|
-
|
|
Jul 26
2022
|
Alessandro Maselli President & CEO |
SELL
Open market or private sale
|
Direct |
816
-3.15%
|
$86,496
$106.9 P/Share
|
|
Jul 26
2022
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
651
+3.55%
|
-
|
|
Jul 26
2022
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Open market or private sale
|
Direct |
312
-1.8%
|
$33,072
$106.9 P/Share
|